No Data
No Data
Canadian Investment Regulatory Organization Trading Halt - APC.H
Advanced Proteome Therapeutics to Proceed With Its Proposed Plan of Arrangement
Burnaby, British Columbia--(Newsfile Corp. - March 6, 2023) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") is pleased to announce that all conditions hav
Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the "Company") is pleased to announce that it has appoi
Advanced Proteome Therapeutics Announces Warrant Extension
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that, it has applied to the TSX V
Advanced Proteome Therapeutics Update on Plans for 2022
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company"), is pleased to announce that its US subsi